Phage display for site-specific immunization and characterization of high-risk human papillomavirus specific E7 monoclonal antibodies

Journal of Immunological Methods

Volumn 337, Issue 2, 2008, Pages 88-96

  Lidqvist, Maria ^a   Nilsson, Olle ^a   Holmgren, Jan ^b   Hall, Christina ^a   Fermér, Christian ^a  

^a Fujirebio Diagnostics Inc   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Cervical cancer; Epitope mapping; Human papillomavirus (HPV); Monoclonal antibody; Oncoprotein E7; Phage display

Indexed keywords

CELL PROTEIN; E7 16-1 MONOCLONAL ANTIBODY; E7 16-2 MONOCLONAL ANTIBODY; E7 16-9 MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY; PROTEIN E7; VIRUS PROTEIN;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; B LYMPHOCYTE; COMPARATIVE STUDY; CONTROLLED STUDY; EPITOPE MAPPING; FEMALE; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; HYBRIDOMA; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOCYTOCHEMISTRY; MOUSE; MYELOMA CELL; NONHUMAN; PHAGE DISPLAY; PRIORITY JOURNAL; WESTERN BLOTTING;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; EPITOPE MAPPING; FEMALE; IMMUNIZATION; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRUS VACCINES; PEPTIDE LIBRARY;

ANIMALIA; HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; MUS;

EID: 49649105446     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jim.2008.06.002     Document Type: Article

References (31)

1. Barbas III C.F., Burton D.R., Scott J.K., and Silverman G.J. Phage Display: A Laboratory Manual (2001), Cold Spring Harbor Laboratory Press, New York
2. Bastien N., Trudel M., and Simard C. Protective immune responses induced by the immunization of mice with a recombinant bacteriophage displaying an epitope of the human respiratory syncytial virus. Virology 234 (1997) 118
3. Branca M., Giorgi C., Santini D., Di Bonito L., Ciotti M., Costa S., Benedetto A., Casolati E.A., Favalli C., Paba P., Di Bonito P., Mariani L., Syrjanen S., Bonifacio D., Accardi L., Zanconati F., and Syrjanen K. Survivin as a marker of cervical intraepithelial neoplasia and high-risk human papillomavirus and a predictor of virus clearance and prognosis in cervical cancer. Am. J. Clin. Pathol. 124 (2005) 113
4. Chakrabarti O., and Krishna S. Molecular interactions of 'high risk' human papillomaviruses E6 and E7 oncoproteins: implications for tumour progression. J. Biosci. 28 (2003) 337
5. Chellappan S., Kraus V.B., Kroger B., Munger K., Howley P.M., Phelps W.C., and Nevins J.R. Adenovirus E1A, simian virus 40 tumor antigen, and human papillomavirus E7 protein share the capacity to disrupt the interaction between transcription factor E2F and the retinoblastoma gene product. Proc. Natl. Acad. Sci. U. S. A. 89 (1992) 4549
6. Chenna R., Sugawara H., Koike T., Lopez R., Gibson T.J., Higgins D.G., and Thompson J.D. Multiple sequence alignment with the Clustal series of programs. Nucleic Acids Res. 31 (2003) 3497
7. Cuzick J., Mayrand M.H., Ronco G., Snijders P., and Wardle J. Chapter 10: new dimensions in cervical cancer screening. Vaccine 24 Suppl 3 (2006) S90
8. Davies P., Arbyn M., Dillner J., Kitchener H.C., Meijer C.J., Ronco G., and Hakama M. A report on the current status of European research on the use of human papillomavirus testing for primary cervical cancer screening. Int. J. Cancer 118 (2006) 791
9. De Berardinis P., Sartorius R., Fanutti C., Perham R.N., Del Pozzo G., and Guardiola J. Phage display of peptide epitopes from HIV-1 elicits strong cytolytic responses. Nat. Biotechnol. 18 (2000) 873
10. de la Cruz V.F., Lal A.A., and McCutchan T.F. Immunogenicity and epitope mapping of foreign sequences via genetically engineered filamentous phage. J. Biol. Chem. 263 (1988) 4318
11. de StGroth S.F., and Scheidegger D. Production of monoclonal antibodies: strategy and tactics. J. Immunol. Methods 35 (1980) 1
12. Dehn D., Torkko K.C., and Shroyer K.R. Human papillomavirus testing and molecular markers of cervical dysplasia and carcinoma. Cancer 111 (2007) 1
13. Delmastro P., Meola A., Monaci P., Cortese R., and Galfre G. Immunogenicity of filamentous phage displaying peptide mimotopes after oral administration. Vaccine 15 (1997) 1276
14. Demangel C., Lafaye P., and Mazie J.C. Reproducing the immune response against the Plasmodium vivax merozoite surface protein 1 with mimotopes selected from a phage-displayed peptide library. Mol. Immunol. 33 (1996) 909
15. Durst M., Glitz D., Schneider A., and zur Hausen H. Human papillomavirus type 16 (HPV 16) gene expression and DNA replication in cervical neoplasia: analysis by in situ hybridization. Virology 189 (1992) 132
16. Frenkel D., Katz O., and Solomon B. Immunization against Alzheimer's beta-amyloid plaques via EFRH phage administration. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 11455
17. Galfre G., Monaci P., Nicosia A., Luzzago A., Felici F., and Cortese R. Immunization with phage-displayed mimotopes. Methods Enzymol. 267 (1996) 109
18. Grabowska A.M., Jennings R., Laing P., Darsley M., Jameson C.L., Swift L., and Irving W.L. Immunisation with phage displaying peptides representing single epitopes of the glycoprotein G can give rise to partial protective immunity to HSV-2. Virology 269 (2000) 47
19. Jensen-Jarolim E., Leitner A., Kalchhauser H., Zurcher A., Ganglberger E., Bohle B., Scheiner O., Boltz-nitulescu G., and Breiteneder H. Peptide mimotopes displayed by phage inhibit antibody binding to bet v 1, the major birch pollen allergen, and induce specific IgG response in mice. FASEB J. 12 (1998) 1635
20. Kitchener H.C., Castle P.E., and Cox J.T. Chapter 7: achievements and limitations of cervical cytology screening. Vaccine 24 Suppl 3 (2006) S63
21. Magliani W., Polonelli L., Conti S., Salati A., Rocca P.F., Cusumano V., Mancuso G., and Teti G. Neonatal mouse immunity against group B streptococcal infection by maternal vaccination with recombinant anti-idiotypes. Nat. Med. 4 (1998) 705
22. Manoutcharian K., Terrazas L.I., Gevorkian G., Acero G., Petrossian P., Rodriguez M., and Govezensky T. Phage-displayed T-cell epitope grafted into immunoglobulin heavy-chain complementarity-determining regions: an effective vaccine design tested in murine cysticercosis. Infect. Immun. 67 (1999) 4764
23. Munger K., and Howley P.M. Human papillomavirus immortalization and transformation functions. Virus Res. 89 (2002) 213
24. Peck R., Schweizer J., Weigl B., Somoza C., Silver J., Sellors J., and Lu P. A magnetic immunochromatographic strip test for detection of human papillomavirus 16 E6. Clin. Chem. 52 (2006) 2170
25. Sambrook J., and Russell D. Molecular Cloning, a Laboratory Manual (2001), Cold Spring Harbour Laboratory Press, Cold Spring Harbour, New York
26. Saqi A., Pasha T.L., McGrath C.M., Yu G.H., Zhang P., and Gupta P. Overexpression of p16INK4A in liquid-based specimens (SurePath) as marker of cervical dysplasia and neoplasia. Diagn. Cytopathol. 27 (2002) 365
27. Walboomers J.M., Jacobs M.V., Manos M.M., Bosch F.X., Kummer J.A., Shah K.V., Snijders P.J., Peto J., Meijer C.J., and Munoz N. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J. Pathol. 189 (1999) 12
28. Wan Y., Wu Y., Bian J., Wang X.Z., Zhou W., Jia Z.C., Tan Y., and Zhou L. Induction of hepatitis B virus-specific cytotoxic T lymphocytes response in vivo by filamentous phage display vaccine. Vaccine 19 (2001) 2918
29. Wollscheid V., Kuhne-Heid R., Stein I., Jansen L., Kollner S., Schneider A., and Durst M. Identification of a new proliferation-associated protein NET-1/C4.8 characteristic for a subset of high-grade cervical intraepithelial neoplasia and cervical carcinomas. Int. J. Cancer 99 (2002) 771
30. zur Hausen H. Intracellular surveillance of persisting viral infections. Human genital cancer results from deficient cellular control of papillomavirus gene expression. Lancet 2 (1986) 489
31. zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat. Rev., Cancer 2 (2002) 342